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Angiostrongylus cantonensis is a nematode parasite that causes eosinophilic meningoencephalitis in humans. Disease presents
following the ingestion of third-stage larvae residing in the intermediate mollusk host and disease manifests as an acute
inﬂammation of the meninges characterized by eosinophil inﬁltrates which release a battery of proinﬂammatory and cytotoxic
agentsinresponsetothepathogen.Asamechanismofneutralizingthesehostdefenses,A.cantonensisexpressesdiﬀerentmolecules
with immunomodulatory properties that are excreted or secreted (ES). In this paper we discuss the role of ES proteins on disease
exacerbation and their potential use as therapeutic targets.
1.Introduction
Establishment of parasitic infections is dependent on a deli-
cate and constant interaction between host and parasite, spe-
ciﬁcally, interactions between the host immune system and
molecules released by the parasite or located at the parasite
surface [1, 2]. Parasitic organisms have evolved the ability to
survive in such hostile environments by evading or neutral-
izing host defense systems. This process is mediated in part
by molecules released by parasites that consist of excretion
and secretion (ES) products which may contain metabolites,
enzymes, hormone-like factors, antioxidants, and proteinase
inhibitors among others [3, 4].
Eosinophilic meningitis, also known as cerebral angios-
trongyliasis, is an acute inﬂammation caused mainly due
the presence of Angiostrongylus cantonensis young in the
meninges, parenchyma of the medulla, pons, or cerebellum
[5]. Humans get infected after ingestion of third-stage lar-
vae residing in raw mollusks, vegetables, or contaminated
water. To date, more than two thousand angiostrongyliasis
cases have been reported, with most cases occurring in
Southeast Asia and the Paciﬁc Islands where the disease is
endemic [6]. However, angiostrongyliasis cases have now
been reported in regions of the world where this disease has
notpreviouslybeenreported,thatis,Brazil,Caribe,Ecuador,
Australia, and the USA. This change in the epidemiology of
angiostrongyliasis should serve as a warning to authorities
that this disease is an emerging public health problem [7–
10].
The pathogenicity and pathophysiology of cerebral angi-
o s t r o n g y l i a s i s ,h o w e v e r ,s t i l lr e m a i np o o r l yd e ﬁ n e d .T h e
present paper discusses the potential role of excreted and se-
creted (ES) proteins in relation to Angiostrongylus infections
in the context of developing novel diagnostic and treatment
modalities.
2. Eosinophils andMeningoencephalitis
Eosinophils play a critical role in protection against hel-
minthes and in mediating allergic responses. Eosinophils
possess specialized granules containing a battery of proin-
ﬂammatory and cytotoxic agents. In addition, various
molecules, including interleukin- (IL-2), 4, 5, 10, 12, 13, 16,
18, TGF-α/β, leukotrienes, proteases, reactive oxygen species
(ROS), and nitric oxide (NO) secreted by eosinophils can
play important roles in mediating protective antihelminthic
responses [11, 12]. However, producing these molecules can
damage cell membranes and tissues, ultimately contributing2 International Journal of Inﬂammation
to the pathogenesis and pathophysiology associated with hy-
pereosinophilic syndromes [13].
Cerebralangiostrongyliasisischaracterizedbyeosinophil
inﬁltrates that kill immature worms residing in the meninges
[14]. Sasaki and coworkers [15] demonstrated enhanced
intracranial survival of A. cantonensis when eosinophilic
responses were inhibited following treatment with anti-IL-5
antibodies [15]. By contrast, mice overexpressing IL-5 killed
worms faster and female worms were smaller than those
developing in wild-type mice [16] .T h es a m er e s u l t sw e r e
observed with another Angiostrongylus species, for example,
A. costaricensis that causes abdominal angiostrongyliasis, a
disease also associated with eosinophilia [17].
IL-5 is an important cytokine associated with the pro-
gression of eosinophilia following an A. cantonensis infection
[16]. Speciﬁcally, IL-5 levels were signiﬁcantly elevated in
the CSF and peripheral blood of patients with eosinophilic
meningoencephalitis due to infections with A. cantonensis
[18, 19], corroborating previous data generated in mouse
models of disease [16, 20].
Several studies have focused on developing therapeu-
tic strategies designed to prevent eosinophil inﬁltrates by
eliciting a switch from a Th-2 to a Th-1 type of response.
Du et al. [21] observed decreased IL-5 levels and elevated
INF-γ levels in mice when an antihelminthic drug was
administrated in combination with IL-12 in an experimental
A. cantonensis infection model [21]. Another study using
antihelminthic drugs in combination with steroids (to avoid
severe inﬂammation due to larval death in the meninges)
determined that in patients receiving both drugs, the IL-5
levels and peripheral eosinophil counts were reduced [19].
Recently, Chuang et al. demonstrated that administration
of an anti-CCR3 monoclonal antibody that blocked the
major receptor present on eosinophils (CCR3) reduced
eosinophil inﬁltrates and consequently reduced the severity
of neurological damage in mice [22].
These data suggested that controlling the level of
eosinophil inﬁltrates and the polarization of Th-2 responses
may reduce neurological damage resulting from A. canto-
nensis infections. A better understanding of the host-parasite
interplay would facilitate the development of diﬀerent
approaches for disease treatment and reduction of disease-
associated sequelae.
3.ReleasedAngiostrongylus cantonensis
Molecules andTheir PotentialRoles in
Disease
Direct leucocyte chemoattractants for eosinophil cells have
been found during in vitro studies of many parasites released
molecules, including Angiostrongylus cantonensis [23]; how-
ever, the identity of those molecules is poorly known [24].
ES released by parasites are likely key to parasite survival
since ES are continuously released and may promote tissue
penetration, nutrient acquisition, and also immune system
and oxidative stress evasion [3]. Studies of ES products from
third-stage A. cantonensis larvae have demonstrated serine
protease and metalloprotease activity likely associated with
duodenal penetration [25]. We previously demonstrated the
presence of high levels of antioxidant enzymatic activities
in ES fractions of adult A. cantonensis worms, including
superoxide dismutase (SOD) and catalase (CAT), whic may
be involved in parasite survival against oxidative stress
generated by host immune responses [26]. Another recent
study investigating immunoreactive proteins from adult ES
preparations identiﬁed peroxiredoxin, serine proteases, heat-
shock proteins, ferritin, galectin, aldolase, and proteases
inhibitors [27]. The potential role of these proteins on in-
ﬂammatory processes and disease exacerbation is discussed
in the following.
3.1. Peroxiredoxin. Antioxidant proteins mediate important
protective mechanism against ROS generated by the host
immune response [3]. Peroxiredoxin (Prx) is an enzyme
reported to exist in many parasites and known to play a cen-
tral role in H2O2 detoxiﬁcation. However, another function
has been attributed to Prx; for example, Fasciola hepatica ES
products containing Prx have been shown to downregulate
Th-1 type responses and to aﬀect macrophage activation
following injection into mice [28]. In another study, neutral-
ization of secreted Prx during the course of an F. hepatica
infection signiﬁcantly reduced the Th-2 responses [29],
indicating that Prx is a target for disease treatment. Indeed,
knocking down the S. mansoni Prx genes using RNA-i dra-
maticallyincreasedoxidativedamagetoparasiteproteinsand
lipids, which in turn reduced worm survival [30]. Prx was
f o u n di nE Sp r o d u c t so fa d u l tA. cantonensis worms that
were recognized by immunoglobulins present in the serum
of infected patients [27]. Interestingly, as mentioned above,
local Th-2 responses were implicated in the development
of CSF and peripheral eosinophilia associated with A.
cantonensis infections [16], and elimination of the worm
combined with IL-12 administration shifted the response
fromaTh-2toaTh-1typeresponse[21].Theseobservations
raised the following hypothesis: blocking A. cantonensis Prx
activity would make the parasite vulnerable and weaken
the Th-2 response, making this molecule a viable treatment
target.
3.2. Heat Shock Proteins. Heat shock proteins are a highly
conserved group of proteins present in both prokaryotic
and eukaryotic organisms. They are grouped into diﬀerent
families based on their molecular weights. HSPs function as
chaperones, assisting in the proper folding of newly syn-
thesized proteins even though HSPs were ﬁrst associated
with stress-induced stimuli [31]. HSP70 has been identiﬁed
in ES preparations of many parasites, including A. canto-
nensis [27]. HSP70 is involved during adaptive response
associated with the early stages of infection with the
nematode Trichinella spiralis [32]; and HSPs have also been
associated with drug resistance in various Leishmania spp.
protozoans [33]. In addition, knocking down HSP90 in
adult Caenorhabditis elegans worms using RNA-i resulted in
cessation of egg production and in an embryonic lethal phe-
notype [34, 35]. Interestingly, inhibiting oviposition is of
special interest as a new treatment alternative for abdominalInternational Journal of Inﬂammation 3
angiostrongyliasis because eggs play a central role in patho-
genesis [36], thereby making Angiostrongylus HSPs viable
targets for disease treatment.
Administration of recombinant HSP from the protozoan
Trypanosoma carassii activated goldﬁsh macrophages in vitro
and stimulated the production of the proinﬂammatory
cytokines INFγ and TNFα [37]. Indeed, secreted HSP forms
have been demonstrated to bind Toll-like receptors 2 and
4 (TLR2 and TLR4) expressed on the surface of antigen-
presenting cells (APCs) in a similar manner as lipopolysac-
charide (LPS) [38], resulting in the production of proinﬂam-
matory cytokines. Moreover, HSPs have been considered to
play a role in the development and pathogenesis of some
rheumatic diseases [39]. Together, these data suggested that
released A. cantonensis HSPs may facilitate the inﬂammatory
process, making further studies to better understand the role
of this protein in disease pathology crucial.
3.3. Galectin. Galectins are a family of sugar-binding pro-
teins with aﬃnity for N-acetyl lactosamines, an interaction
mediated via a conserved carbohydrate-recognition domain
(CRD). In mammals, these proteins possess the ability
of modulate inﬂammatory responses. Galectin-1 has been
demonstrated to inhibit Th1 diﬀerentiation, leading to Th2
responses[40].Ontheotherhand,galectin-9,anothermam-
malian galectin, has been shown to reduce Th2-associated
airway inﬂammation [41]. However, the function of hel-
minth galectins still remains unclear even though Brugia
malayi and Onchocerca volvulus galectins have been hypoth-
esized to function as potential immune modulators [42,
43]. One of the most important classes of antigens ex-
pressedbyseveralhelminthsiscomprisedofsugarmolecules.
Interestingly, helminthes activate innate immune cells via
surface-expressed or -secreted products, including glycol-
ipids and glycoproteins, through lectin receptors [44]. This
association may interfere with the induction of eﬀective
immune responses that could contribute to the modulation
of inﬂammatory T-cell responses [45]. In fact, the Schisto-
soma egg glycan did not upregulate stimulatory molecules or
produce cytokines when it was recognized and internalized
by immature dendritic cells (iDCs), indicating that con-
ventional maturation of dendritic cells induced by Toll-like
r e c e p t o r sa g o n i s t sw a sp r e v e n t e d[ 46]. Moreover, galectins
have also been identiﬁed as targets for disease diagnosis,
for example, diagnosis of Trichostrongylus colubriformis (gas-
trointestinal nematode) infections in sheep [47]. In similar
fashion, an ES galectin from A. cantonensis was shown to
be immunoreactive to antibodies present in serum from
angiostrongyliasis patients, further supporting the potential
use of this protein as a diagnostic antigen [27].
3.4. Proteases. Proteases are enzymes that catalyze the
cleavage of amide linkages in macromolecular proteins
and oligomeric peptides. Proteases are very important for
parasite survival because they facilitate tissue penetration
and nutrient acquisition. For example, hemoglobinases are
proteases that degrade hemoglobin into peptides and amino
acids, a fundamental process for nutrient acquisition for
many parasites. Hemoglobinases from hookworms have
been suggested as potential vaccine targets because of
their immunogenicity and because their inactivation would
interfere with hookworm feeding [48]. Our previous work
demonstrating that hemoglobinases present in ES prod-
ucts from adult worms were recognized by sera from
angiostrongyliasis-infected patients supports these observa-
tions. In addition, these enzymes may constitute therapeutic
t a r g e t sa so b s e r v e db yS i j w a l ie ta l .[ 49]w h od e m o n s t r a t e d
that disruption of falcipain-2 protein (an enzyme involved in
Plasmodiumfalciparumhemoglobindegradation)resultedin
ﬁtness injuries to early-stage trophozoites [49]. It is reason-
able therefore to hypothesize that blocking hemoglobinase
activity would interfere with nutrient uptake resulting in
death of the parasite. In fact, knocking down an S. mansoni
hemoglobinase resulted in signiﬁcant growth retardation in
vitro[50]. A parallel approach targeting enzymes responsible
for sugardigestion (suchas aldolase and beta-amylase) could
also result in parasite elimination.
Another protein identiﬁed in ES samples was a cathepsin
B-like protein, which is a cysteine protease. Cystein pro-
teases from helminthes have been shown to be involved
in degrading host proteins, including immunoglobulins,
complement components, kininogen, hemoglobin, albumin,
and extracellular matrix proteins [51]. Interestingly, cysteine
proteases from ES preparations of Paragonimus westermani,
a tissue-invasive parasite that causes either pulmonary or
extrapulmonary paragonimiasis in humans, were also impli-
catedinhumaneosinophil degranulationinvitro [52].These
ﬁndings may help in the understanding of the mechanisms
of tissue inﬂammation associated with meningoencephalitis
due to A. cantonensis infections since the cathepsin B-like
protein was secreted by the parasite.
3.5. Proteases Inhibitors. Besides secreted proteases, parasitic
organisms also have the ability to produce and release
inhibitors for many types of proteases that may block
host protease function, thereby facilitating parasite survival.
Three kinds of protease inhibitors are commonly described
in parasites: aspins, speciﬁc to aspartic proteases, cystatins,
which block the activity of cysteine proteases, and serpins,
which act on serine proteases.
A cystatin from A. cantonensis (AcCystatin) was iden-
tiﬁed from a cDNA library of fourth-stage larvae that was
cloned and expressed in a prokaryotic system. The authors
observedthatrecombinantAcCystatinsigniﬁcantlyinhibited
cathepsin B and signiﬁcantly upregulated nitric oxide pro-
duction by IFNγ-activated macrophages [53]. Interestingly,
cystatins identiﬁed from parasitic nematodes have been
implicated in blocking cathepsin activity; however, they
are also associated with stimulating the production of
anti-inﬂammatory cytokines [54]. These cystatin properties
suggest that they can inhibit cellular proliferation while con-
comitantly establishing an anti-inﬂammatory environment
favorable to parasite survival [55]. As therapeutic targets,
these inhibitors have been demonstrated to prevent allergic
inﬂammation in both lung and intestines of mice treated
with a ﬁlarial cystatin that modulated macrophage-mediated4 International Journal of Inﬂammation
colitis, in addition to inhibiting eosinophil recruitment,
downregulating IL-4 production, and suppressing allergic
airway hyper-reactivity [56].
An aspartyl protease inhibitor secreted by A. cantonensis
female adult worms was identiﬁed in an in vitro study [27];
however, the role of aspins in helminthes is not clear. Poten-
tially, these proteins could block the activity of host aspartyl
proteases. Nevertheless, the activity of porcine pepsin was
not inhibited by a recombinant hookworm aspartic pro-
teinase inhibitor [57]. To date, only aspins have been
reported in the role of A. cantonensis proteinase inhibitors
[58]. However, molecular analysis of the A. cantonensis
genome revealed that only a small number of sequences have
been deposited at Genbank. As a consequence, protein iden-
tiﬁcation by mass spectrometry is ineﬀective since the lack
of peptide sequence homology to related proteins from other
organisms makes identiﬁcation diﬃcult.
4. Conclusions
The pathogenesis of eosinophilic meningitis is related to
the development of signiﬁcant inﬂammatory reactions in
response to A. cantonensis worms residing in the nervous
system.Inresponsetotheinfection,eosinophilsarerecruited
and severalpotent cytotoxic agentsarereleased in anattempt
to eliminate the pathogen. This immune-mediated attack
frequently results in tissue damage and ultimately may
exacerbate disease severity. In this paper, we discussed the
putative diverse roles of released A. cantonensis molecules.
Manykindsofmoleculesmayactasimmunomodulators,but
thesemoleculesmayalsobeinvolvedindiseaseexacerbation.
Further studies using recombinant forms of the target
proteins discussed above will be essential in evaluating and
conﬁrming the hypothesis presented here.
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